Close Menu

Pathogenetix

Jonathan Rothberg has resigned from his position as CEO of Life Technologies' Ion Torrent business, according to a filing with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.

Bacterial typing systems developer PathoGenetix has hired Paul Krassnoff to be director of manufacturing. In this post, he will develop production and quality assurance systems for the firm's Genome Sequence Scanning System.

PathoGenetix has raised $7.5 million in a second closing of a Series B financing round, bringing its total raised in the round to $11.5 million.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PathoGenetix today announced it has raised $7.5 million in a second closing of a Series B financing round, bringing the total raised in the round to $11.5 million.

The company, formerly called US Genomics, will use the funding to complete development of its system for identifying pathogens in complex biological samples, which is scheduled for commercial release in 2012.

The company, once called US Genomics, will use the funds to complete development of its first commercial systems for identifying pathogens in complex biological samples.

In an SEC filing, the company, which had been called US Genomics, is targeting $1.8 million.

Pages

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.